Fibroblast Growth Factors
"Fibroblast Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.
| Descriptor ID |
D005346
|
| MeSH Number(s) |
D12.644.276.624 D12.776.467.624 D23.529.624
|
| Concept/Terms |
Fibroblast Growth Factors- Fibroblast Growth Factors
- Growth Factors, Fibroblast
- Fibroblast Growth Factor
- Growth Factor, Fibroblast
- Fibroblast Growth Regulatory Factor
- DNA Synthesis Factor
|
Below are MeSH descriptors whose meaning is more general than "Fibroblast Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Fibroblast Growth Factors".
This graph shows the total number of publications written about "Fibroblast Growth Factors" by people in this website by year, and whether "Fibroblast Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 4 | 6 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 5 | 8 |
| 2014 | 1 | 1 | 2 |
| 2015 | 5 | 2 | 7 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 1 | 2 |
| 2022 | 2 | 1 | 3 |
| 2023 | 2 | 0 | 2 |
| 2024 | 0 | 2 | 2 |
| 2025 | 2 | 1 | 3 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibroblast Growth Factors" by people in Profiles.
-
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial. J Bone Miner Res. 2026 Aug 21; 41(9):922-933.
-
Pearls & Oy-sters: SCA27B as an Elusive Genetic Cause of Episodic Neurologic Symptoms in Later Adulthood. Neurology. 2026 Mar 24; 106(6):e214754.
-
Circulating mitokines GDF-15 and FGF21 are associated with frailty, sarcopenia, and malnutrition in older adults: Evidence from the FRASNET study. Mech Ageing Dev. 2025 12; 228:112124.
-
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. N Engl J Med. 2025 Jun 26; 392(24):2413-2424.
-
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial. Am J Nephrol. 2025; 56(4):490-499.
-
Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B). Ann Neurol. 2024 12; 96(6):1092-1103.
-
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients. Am J Nephrol. 2026; 57(4):504-513.
-
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis. Hepatology. 2024 03 01; 79(3):674-689.
-
Pegozafermin for NASH - A Sprint to Start a Marathon. N Engl J Med. 2023 09 14; 389(11):1044-1046.
-
From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19. Am J Respir Cell Mol Biol. 2022 08; 67(2):139-141.